Key facts
- This page summarizes Michael G. Erickson's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 20 reported transactions and 7 derivative rows are listed below.
- Accepted by SEC: 19 Feb 2026, 18:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Options Exercise
Sale
Sale
Sale
Sale
Sale
Sale
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Additional SEC filing notes
Footnote F1
Represents the weighted average price of the shares sold ranging from a low of $623.28 to a high of $624.27 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Footnote F2
Represents the weighted average price of the shares sold ranging from a low of $624.89 to a high of $625.56 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Footnote F3
Represents the weighted average price of the shares sold ranging from a low of $626.045 to a high of $628.38 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Footnote F4
Represents the weighted average price of the shares sold ranging from a low of $627.74 to a high of $628.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Footnote F5
Represents the weighted average price of the shares sold ranging from a low of $628.755 to a high of $629.615 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Footnote F6
Includes 184 vested but deferred restricted stock units.
Footnote F7
Grant of option to buy shares of Issuer common stock that vested in five annual installments beginning on February 14, 2018.
Footnote F8
Grant of option to buy shares of Issuer common stock that vested in five annual installments beginning on February 14, 2019.
Footnote F9
Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2022.
Footnote F10
Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2023.
Footnote F11
Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2024.
Footnote F12
Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2025.
Footnote F13
Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2026.